Department of Cardiology, Charité Universitätsmedizin Berlin, Germany.
Arch Pathol Lab Med. 2011 Feb;135(2):243-8. doi: 10.5858/135.2.243.
Chronic Chagas disease (15 million patients; annual incidence, 40, 000 patients; annual mortality, 12 ,500 patients) is the most serious parasitic disease in Latin America. Between 10 and 30 years after infection, 30% of patients with Chagas disease develop heart injury, which is the main reason for its high mortality. Consequently, frequent cardiac diagnostics are required for patients with Chagas disease.
To minimize time-intensive and cost-intensive diagnostics, such as electrocardiography, echocardiography, and radiologic imaging, we tested the effect of measuring serum cardiac troponin T (cTnT) with a highly sensitive assay. To indicate the pathophysiologic background for cTnT release in Chagas heart injury, inflammation markers, such as C-reactive protein and interleukin 6, were measured in parallel.
Serum cTnT was measured in 26 healthy subjects and in 179 patients with chronic Chagas disease who were asymptomatic (indeterminate stage, n = 86), who were suffering from cardiomyopathy with or without megacolon (n = 71), or who were suffering from megacolon exclusively (n = 22).
Serum cTnT was significantly higher in patients with cardiomyopathy with or without megacolon than in healthy subjects, asymptomatic subjects, and patients with megacolon, and the cTnT value was correlated with the severity of the cardiomyopathy. The lower limit of detection for the highly sensitive assay (3 ng/L) was best at distinguishing patients with, and without, heart injury. C-reactive protein and interleukin 6 were found to parallel cTnT changes in both the different Chagas groups and the cardiomyopathy groups separated by disease severity.
Highly sensitive cTnT measurement has the potential to contribute to diagnosis and monitoring of heart injury in patients with chronic Chagas disease. The highly sensitive assay of cTnT release seems to be related to Chagas heart disease-specific inflammation.
慢性恰加斯病(1500 万患者;年发病率 4 万例;年死亡率 1.25 万例)是拉丁美洲最严重的寄生虫病。在感染后 10 至 30 年内,30%的恰加斯病患者会出现心脏损伤,这也是其高死亡率的主要原因。因此,需要对恰加斯病患者进行频繁的心脏诊断。
为了减少心电图、超声心动图和影像学等时间和成本密集型的诊断方法,我们测试了使用高敏检测方法测量血清心肌肌钙蛋白 T(cTnT)的效果。为了表明 cTnT 在恰加斯病心脏损伤中的释放的病理生理背景,我们平行测量了炎症标志物,如 C 反应蛋白和白细胞介素 6。
我们测量了 26 名健康受试者和 179 名慢性恰加斯病患者的血清 cTnT,这些患者无症状(不确定期,n = 86)、患有心肌病伴或不伴巨结肠(n = 71)或仅患有巨结肠(n = 22)。
患有心肌病伴或不伴巨结肠的患者的血清 cTnT 明显高于健康受试者、无症状患者和仅患有巨结肠的患者,且 cTnT 值与心肌病的严重程度相关。高敏检测方法(3ng/L)的检测下限最能区分有和无心脏损伤的患者。C 反应蛋白和白细胞介素 6在不同的恰加斯组和按疾病严重程度分离的心肌病组中都与 cTnT 的变化平行。
高敏 cTnT 测量有可能有助于诊断和监测慢性恰加斯病患者的心脏损伤。cTnT 释放的高敏检测似乎与恰加斯心脏病特有的炎症有关。